Introduction Type 2 diabetes mellitus (T2DM) is a progressive metabolic disorder associated with microvascular and macrovascular complications, including cardiovascular disease and chronic kidney disease (1). Sodium-glucose co-transporter 2 (SGLT2) inhibitors, such as dapagliflozin, have emerged as effective glucose-lowering therapies with addition
Complicated case of Osteoarthritis
1850 Reached2 Comments3 Likes
Woman presented with Fever of Unknown Origin
7724 Reached93 Comments19 Likes
Switching from Premixed Insulin to Basal Insulin with OADs
1083 Reached2 Comments6 Likes
Case of Adolescent with Severe Macrocytic Anaemia
52793 Reached502 Comments51 Likes
Study evaluating Effectiveness of Bacillus clausii for Treatment of Rotavirus Infection
1303 Reached4 Comments6 Likes